PDL BioPharma Shares Increased Today, But Investors Remain Skeptical About Company’s Growth
On Friday, biopharmaceutical royalty company PDL BioPharma Inc. (NASDAQ:$PDLI) saw its shares soar. It all started after the Nevada-based company reported positive second-quarter earnings. A quarterly net profit that was 827% higher than PDL BioPharma …
Gilead Sciences sees Stock Rise After Beating Expectations
During after-hours trading on July 26, biotechnology pharmaceutical company Gilead Sciences Inc.’s (NASDAQ:$GILD) stock went up by 2.6% to reach $76.10. The rise was largely due to Gilead Sciences’ release of its second quarter earnings …
After Reporting Q2 Profit and Revenue Beats, Biogen’s Shares Climbed 5.8%
Biogen Inc. (NASDAQ:$BIIB) reported Q2 profit and revenue beats on Tuesday, which caused Biogen’s shares to climb 5.8% in premarket trade.
Let’s dive into the numbers:
Earnings for the latest quarter …
Shares of Sarepta Therapeutics Are Increasing By More Than 20%
On Wednesday, July 19, Sarepta Therapeutics Inc. (NASDAQ:$SRPT) brought in revenues that were much higher than expected in its Q2 earnings report. As a result, the stock increased by more than 20%.
According …
Vertex Pharmaceuticals Shares Increased 24% Today
On July 18, Vertex Pharmaceuticals Inc. (NASDAQ:$VRTX) shares skyrocketed in an after hours trading session. This added about $8 billion to the Boston-based company’s value. What caused the increase? Shares of the company soared after …
5 Pharma and Biotech Stocks to Watch as We Approach the Healthcare Sector Earnings
It seems like pharmaceutical and biotech stocks are making a comeback. And there are several, justifiable reasons for this improved performance. For starters, investors seem to be more comfortable with the drug pricing scenario and …
5 Things Marijuana Investors Need to Know About Zynerba Pharmaceuticals
If you’re looking to invest in marijuana, you should know that there are three specific types of marijuana stocks on the market – manufacturer stocks, equipment stocks, and biotech stocks. The stock that we are …
Cara Therapeutics Stock Increases After Revealing Promising Data From a Phase 1 Drug Trial
On Wednesday, Cara Therapeutics (NASDAQ:$CARA) stock increased after the biotech company revealed promising data from a Phase 1 drug trial for chronic kidney disease patients.
If you’re a biotech investor, you are probably …
This is Why Ocular Therapeutix Inc.’s Stock Today Fell Despite its Rising Yesterday — July 12, 2017
Ocular Therapeutix’s (NASDAQ:$OCUL) stock fell again on July 12 by 20.5% as of 12:55 PM EDT. The stock fell after news broke out that Ocular received a complete response letter (CRL) for its lead drug …
Arena Pharmaceuticals Shares Gained 45% Today
If you’re looking for pharmaceutical companies to invest in, you might want to brush up on what’s been happening in the sector as of late.
After Arena Pharmaceuticals (NASDAQ:$ARNA) announced that its experimental …